BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16728701)

  • 1. Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.
    Shen RR; Ferguson DO; Renard M; Hoyer KK; Kim U; Hao X; Alt FW; Roeder RG; Morse HC; Teitell MA
    Blood; 2006 Sep; 108(6):1991-8. PubMed ID: 16728701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation.
    Kuraishy AI; French SW; Sherman M; Herling M; Jones D; Wall R; Teitell MA
    Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10175-80. PubMed ID: 17548807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas.
    Dawson DW; Hong JS; Shen RR; French SW; Troke JJ; Wu YZ; Chen SS; Gui D; Regelson M; Marahrens Y; Morse HC; Said J; Plass C; Teitell MA
    Oncogene; 2007 Jun; 26(29):4243-52. PubMed ID: 17260020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation.
    Rivas MA; Meydan C; Chin CR; Challman MF; Kim D; Bhinder B; Kloetgen A; Viny AD; Teater MR; McNally DR; Doane AS; Béguelin W; Fernández MTC; Shen H; Wang X; Levine RL; Chen Z; Tsirigos A; Elemento O; Mason CE; Melnick AM
    Nat Immunol; 2021 Feb; 22(2):240-253. PubMed ID: 33432228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models.
    Mossadegh-Keller N; Brisou G; Beyou A; Nadel B; Roulland S
    Front Immunol; 2021; 12():683597. PubMed ID: 34335584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCL1 in B-cell tumors retains its normal b-cell pattern of regulation and is a marker of differentiation stage.
    Herling M; Patel KA; Hsi ED; Chang KC; Rassidakis GZ; Ford R; Jones D
    Am J Surg Pathol; 2007 Jul; 31(7):1123-9. PubMed ID: 17592280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma.
    Gu X; Booth CJ; Liu Z; Strout MP
    Blood; 2016 Jan; 127(1):102-12. PubMed ID: 26385350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice deficient for CD137 ligand are predisposed to develop germinal center-derived B-cell lymphoma.
    Middendorp S; Xiao Y; Song JY; Peperzak V; Krijger PH; Jacobs H; Borst J
    Blood; 2009 Sep; 114(11):2280-9. PubMed ID: 19608748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas.
    Frank MJ; Dawson DW; Bensinger SJ; Hong JS; Knosp WM; Xu L; Balatoni CE; Allen EL; Shen RR; Bar-Sagi D; Martin GR; Teitell MA
    Blood; 2009 Mar; 113(11):2478-87. PubMed ID: 19147787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the Origin of Human Germinal Center B Cell-Derived Malignancies.
    Seifert M; Küppers R
    Methods Mol Biol; 2017; 1623():253-279. PubMed ID: 28589362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the catalytic function of activation-induced cytidine deaminase promotes apoptosis of germinal center B cells in BXD2 mice.
    Hsu HC; Yang P; Wu Q; Wang JH; Job G; Guentert T; Li J; Stockard CR; Le TV; Chaplin DD; Grizzle WE; Mountz JD
    Arthritis Rheum; 2011 Jul; 63(7):2038-48. PubMed ID: 21305519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AID is required for germinal center-derived lymphomagenesis.
    Pasqualucci L; Bhagat G; Jankovic M; Compagno M; Smith P; Muramatsu M; Honjo T; Morse HC; Nussenzweig MC; Dalla-Favera R
    Nat Genet; 2008 Jan; 40(1):108-12. PubMed ID: 18066064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma.
    Said JW; Hoyer KK; French SW; Rosenfelt L; Garcia-Lloret M; Koh PJ; Cheng TC; Sulur GG; Pinkus GS; Kuehl WM; Rawlings DJ; Wall R; Teitell MA
    Lab Invest; 2001 Apr; 81(4):555-64. PubMed ID: 11304575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma.
    Hoyer KK; French SW; Turner DE; Nguyen MT; Renard M; Malone CS; Knoetig S; Qi CF; Su TT; Cheroutre H; Wall R; Rawlings DJ; Morse HC; Teitell MA
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14392-7. PubMed ID: 12381789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas and Fas ligand expression on germinal center type-diffuse large B-cell lymphoma is associated with the clinical outcome.
    Kojima Y; Tsurumi H; Goto N; Shimizu M; Kasahara S; Yamada T; Kanemura N; Hara T; Sawada M; Saio M; Yamada T; Takahashi T; Tomita E; Takami T; Moriwaki H
    Eur J Haematol; 2006 Jun; 76(6):465-72. PubMed ID: 16494623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Msh6 protects mature B cells from lymphoma by preserving genomic stability.
    Peled JU; Sellers RS; Iglesias-Ussel MD; Shin DM; Montagna C; Zhao C; Li Z; Edelmann W; Morse HC; Scharff MD
    Am J Pathol; 2010 Nov; 177(5):2597-608. PubMed ID: 20934970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry.
    Dominguez-Sola D; Victora GD; Ying CY; Phan RT; Saito M; Nussenzweig MC; Dalla-Favera R
    Nat Immunol; 2012 Nov; 13(11):1083-91. PubMed ID: 23001145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Ig/BCL6 translocations with germinal center B lymphocytes in human lymphoid tissues: implications for malignant transformation.
    Yang X; Lee K; Said J; Gong X; Zhang K
    Blood; 2006 Sep; 108(6):2006-12. PubMed ID: 16728698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined deletion of Xrcc4 and Trp53 in mouse germinal center B cells leads to novel B cell lymphomas with clonal heterogeneity.
    Chen Z; Elos MT; Viboolsittiseri SS; Gowan K; Leach SM; Rice M; Eder MD; Jones K; Wang JH
    J Hematol Oncol; 2016 Jan; 9():2. PubMed ID: 26740101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response.
    Béguelin W; Teater M; Meydan C; Hoehn KB; Phillip JM; Soshnev AA; Venturutti L; Rivas MA; Calvo-Fernández MT; Gutierrez J; Camarillo JM; Takata K; Tarte K; Kelleher NL; Steidl C; Mason CE; Elemento O; Allis CD; Kleinstein SH; Melnick AM
    Cancer Cell; 2020 May; 37(5):655-673.e11. PubMed ID: 32396861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.